Healthcare · Pharmaceuticals & Biotechnology
QVM read Momentum-led Quality Moderate, Valuation Fairly Valued, Momentum Bullish
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Ranks #104 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.
| Filed | Person | Category | Type | Quantity | Value |
|---|---|---|---|---|---|
| 7 Mar 2026 | TV Praveen | Promoter group | Buy | 0 | ₹0 |
| 29 Dec 2025 | TV Praveen | Promoter group | Buy | 0 | ₹0 |
| 25 Dec 2025 | TV Praveen | Promoter group | Buy | 0 | ₹0 |
| 19 Mar 2025 | TV Praveen | Promoter group | Buy | 0 | ₹0 |
| 19 Mar 2025 | T V V S N MURTHY (HUF) | Promoter | Sell | 0 | ₹0 |
| 19 Mar 2025 | Sudeepthi Gopineedi | Promoter group | Buy | 0 | ₹0 |
| 1 Jul 2024 | TV Praveen | Promoter group | Buy | 0 | ₹0 |
| 25 Apr 2024 | Suresh Babu Potluri | Other | Sell | 0 | ₹0 |
| 29 Mar 2024 | TV Praveen | Promoter group | Buy | 0 | ₹0 |
| 1 Jan 2024 | TV Praveen | Promoter group | Buy | 0 | ₹0 |
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 16 Dec 2025 | BHARADHWAJAN JAGANATHAN VELAMUR | Bulk | Sell | 15,258 | 1312.0500 | NSE |
| 29 Sep 2020 | RAMESH BABU POTLURI | Bulk | Sell | 57,700 | 655.9000 | BSE |
| 29 Sep 2020 | POTLURI LABORATORIES PRIVATE LIMITED | Bulk | Buy | 57,700 | 655.9600 | BSE |
| 7 Jan 2019 | AASHYA FINCOM | Bulk | Buy | 16,007 | 796.5000 | BSE |
| 7 Jan 2019 | AASHYA FINCOM | Bulk | Sell | 16,007 | 790.8200 | BSE |
| 4 Jan 2019 | ESSAR TRADING COMPANY | Bulk | Buy | 20,425 | 731.3800 | BSE |
| 4 Jan 2019 | ESSAR TRADING COMPANY | Bulk | Sell | 20,550 | 728.0400 | BSE |
| Ex-date | Subject | Per share (₹) | Record date |
|---|---|---|---|
| 23 Sep 2026 | Dividend - Rs 1.50 Per Share | 1.5000 | 23 Sep 2026 |
| 24 Sep 2025 | Dividend - Rs 1.50 Per Share | 1.5000 | 24 Sep 2025 |
| 23 Sep 2024 | Annual General Meeting/Dividend - Rs 1.50 Per Share | 1.5000 | 23 Sep 2024 |
| 22 Sep 2023 | Annual General Meeting/Dividend - Rs 1.50 Per Share | 1.5000 | — |
| 22 Sep 2022 | Annual General Meeting/Dividend - Rs 1.50 Per Share | 1.5000 | — |
| 20 Sep 2021 | Annual General Meeting/Dividend - Rs 1.50 Per Share | 1.5000 | — |
| 19 Sep 2019 | Dividend - Rs 1.50 Per Share | 1.5000 | — |
Bonuses, splits, buybacks and other events. Dividends are listed separately above.
| Ex-date | Type | Subject |
|---|---|---|
| — | NAME_CHANGE | Name changed from SMS Lifesciences India Ltd to HALEOS LABS LIMITED |
| 12 Sep 2018 | OTHER | Annual General Meeting |
Quarterly results, AGMs, buybacks and other board-approved business.
| Date | Purpose | Results |
|---|---|---|
| 5 Aug 2026 | Financial Results/Other business matters | Yes |
| 29 May 2026 | Financial Results/Dividend/Other business matters | Yes |
| 11 Feb 2026 | Financial Results/Other business matters | Yes |
| 10 Nov 2025 | Financial Results/Other business matters | Yes |
| 11 Aug 2025 | Financial Results/Other business matters | Yes |
Exchange disclosures (NSE and BSE), most recent first.
| Date | Category | Announcement |
|---|---|---|
| 1 Oct 2026 | AGM/EGM | Haleos Labs Ltd - 540679 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| 1 Oct 2026 | Shareholders meeting | HALEOS LABS LIMITED has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results. |
| 30 Sep 2026 | AGM/EGM | Haleos Labs Ltd - 540679 - Shareholder Meeting / Postal Ballot-Outcome of AGM |
| 30 Sep 2026 | Shareholders meeting | HALEOS LABS LIMITED has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026 |
| 21 Sep 2026 | Trading Window | HALEOS LABS LIMITED has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 21 Sep 2026 | Insider Trading / SAST | Haleos Labs Ltd - 540679 - Closure of Trading Window |
| 18 Sep 2026 | Company Update | Haleos Labs Ltd - 540679 - USFDA Update (Material Subsidiary) |
| 18 Sep 2026 | Disclosure of material issue | HALEOS LABS LIMITED has informed regarding USFDA Update (Material Subsidiary) |
| 9 Sep 2026 | Company Update | Haleos Labs Ltd - 540679 - Annual Report (Weblink) |
| 9 Sep 2026 | Updates | HALEOS LABS LIMITED has informed the Exchange regarding 'Annual Report (Weblink)'. |
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Data unavailable.
Data unavailable.
Data unavailable.
Board of directors and corporate information →
Data unavailable (no single-stock futures or options activity on record for this company).
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.
